Detection and quantitation of thymidylate synthase mRNA in human colon adenocarcinoma cell line resistant to 5-fluorouracil by competitive PCR

Anticancer Research

Volumn 18, Issue 3 A, 1998, Pages 1457-1463

  Shibata, Jiro ^a   Aiba, Keisuke ^a   Shibata, Harumi ^a   Minowa, Sayuri ^a   Horikoshi, Noboru ^a  

^a CANCER CHEMOTHERAPY CENTER   (Japan)

Author keywords

5 Fluorouracil; Competitive PCR; Human colon cancer cell line; TS mRNA

Indexed keywords

FLUOROURACIL; MESSENGER RNA; THYMIDYLATE SYNTHASE;

ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; COLON ADENOCARCINOMA; CONTROLLED STUDY; ENZYME ACTIVITY; GENE AMPLIFICATION; GENE REARRANGEMENT; GROWTH CURVE; HUMAN; HUMAN CELL; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SOUTHERN BLOTTING;

ADENOCARCINOMA; BLOTTING, NORTHERN; CELL LINE; COLONIC NEOPLASMS; DNA PRIMERS; DRUG RESISTANCE, NEOPLASM; FLUOROURACIL; HUMANS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; THYMIDYLATE SYNTHASE; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0031875509     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Bruckner HW and Motwani BT: Chemotherapy of advanced cancer of the colon and rectum. Semin Oncol 18: 443-461, 1991.
2. Cohen AM, Minsky BD and Schilsky RL: Color In: Cancer-Principles and Practice of Oncology (DeVita Jr. VT Hellman S and Rosenberg SA eds.). J. B. Lippincott Co. Philadelphia, 1985, pp 929-977.
3. Pinedo HM and Peters GFJ: Fluorouracil. Biochemistry and pharmacology. J Clin Oncol 6: 1653-1664, 1988.
4. Sommer A and Santi DV: Purification and amino acid analysis of an active site peptide from thymidylate synthase containing covalently bound 5'-fluoro-2'-deoxyuridylate and methylene tetrachloride. Biochem Biophys Res Commun 57: 689-696, 1974.
5. Schuetz JD, Collins JM and Wallace HJ: Alteration of the secondary structure of newly synthesized DNA from murine born marrow cells by 5-fluorouracil. Cancer Res 46: 119-123, 1986.
6. Mandel HG: Incorporation 5-fluorouracil into RNA and its molecular consequence. Prog Mol Subcell Biol 1: 82-135, 1969.
7. Cheng YC and Nakayama K: Effect of 5-fluoro-2'-deoxyuridine on DNA metabolism in HeLa cells. Mol Pharmacol 23: 171-174, 1983.
8. Johnston PG, Liang CM, Henry S, Chabner BA and Allegra CJ: Production and characterization off 15 monoclonal antibodies that localize human thymidylate synthase in the cytoplasm of human cells and tissue. Cancer Res 51: 6668-6676, 1991.
9. Chu E, Zinn S, Boarman D and Allegra CJ: Interaction of gamma interferon and 5-fluorouracil in the H630 human colon carcinoma cell line. Cancer Res 50: 5834-5840, 1990.
10. Chu E, Drake JC, Koeller MK, Zinn S, Jamis-dow CA, Yeh GC and Allegra CJ: Induction of thymidylate synthase associated with multidrug resistance in human colon cancer cell line. Mol Pharmacol 39: 136-143, 1991.
11. Aschele CO, Sobrero A, Faderan MA and Bertino JR: Novel mechanism(s) of resistance to 5-fluorouracil in human colon cancer (HCT-8) sublines following exposure to two different clinically relevant dose schedules. Cancer Res 52: 1855-1864, 1992.
12. Davis ST and Berger SH: Variation in human thymidylate synthase is associated with resistance to 5-fluoro-2'-deoxyuridine. Mol Pharmacol 43: 702-708, 1993.
13. Hughey CT, Barbour KW, Berger FG and Berger SH: Functional effect of a naturally occurring amino acid substitution in human thymidylate synthase. Mol Pharmacol 44: 316-323, 1993.
14. Santi DV: Mutagenesis, structure and function studies of thymidylate synthase. Nucl Acids Rympo Ser 29: 103-105, 1993.
15. Copur S, Aiba K, Drake JC, Allegra CJ and Chu E: Thymidylate synthase gene amplification in human colon cancer cell lines resistant to 5-fluorouracil. Biochem Pharmacol 49: 1419-1426, 1995.
16. Kaneda S, Nalbantoglu J, Takeishi K, Shimizu K, Gotoh O, Seno T and Ayusawa D: Structural and functional analysis of the human thymidylate synthase gene. J Biol Chem 265: 20277-20284, 1990.
17. Peters GJ, Groeningen CJ, Laurensse EJ and Pinedo HM: Thymidylate synthase from untreated human colorectal cancer and colonie mucosa : Enzyme activity and inhibition by 5-fluoro-2'-deoxyuridine-5'-monophosphate. Eur J Cancer 27: 263-267, 1991.
18. Horikoshi T, Danenberg TH, Stadlbauer THW, Volkenandt M, Shea LCC, Aigner K, Gustavsson B, Leichman L, Frosing R, Ray M, Gibson NW, Spears CP and Danenberg PV: Quantitation of thymidylate synthase, dihydrofolate reductase, and DT-diaphorase gene expression in human tumor using the polymerase chain reaction. Cancer Res 52: 108-116, 1992.
19. Park JG, Oie HK, Sugarbaker PH, Henslee JG, Chen TR, Johnson BE and Gazdar A: Characteristics of cell lines established from human colorectal carcinoma. Cancer Res 47: 6410-6418, 1987.
20. Carmichael J, DeGraff WG, Gazder AF, Minna JD and Mitchell JB: Evaluatlon of a tetrazolium-based semiautomated colorimetric assay : assessment of chemosensitivity testing. Cancer Res 47: 936-942, 1987.
21. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
22. Takeishi T, Kaneda S, Ayusawa D, Shimizu K, Gotoh O and Seno T: Nucleotide sequence of a functional cDNA for human thymidylate synthase. Nucleic Acids Res 13: 2035-2043, 1985.
23. Siebert PD and Larrick JW: PCR MIMICS: Competitive DNA fragments for use as internal standards in quantitative PCR. Biotechniques 14: 244-249, 1993.
24. Gilliland G, Perrin S, Blanchard K and Bunn HF: Analysis of cytokine mRNA and DNA: Detection and quantitation by competitive polymerase chain reaction. Proc Natl Acad Sci USA 87: 2725-2729, 1990.
25. Arcari P, Martinelli R and Salvatore F: The Mar complete sequence of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase evidence for multiple mRNA species. Nucleic Acids Res 12: 9179-9189, 1984.
26. Herrmana BG and Frischauf AM: Isolation of genomic DNA. In: Methods. In: Enzymology 152. Academic Inc, pp180-183, 1987.
27. Southern EM: Detection of specific sequence among DNA fragments separated by gel electrophoresis. J Mol Biol 98: 503-517, 1975.
28. Graves RA, Pandey NB, Chodchoy N and Marzluff WF: Translation is required for regulation of histone mRNA degradation. Cell 48: 615-626, 1987.
29. Mowry KL and Steitz JA: Identification of the human U7 snRNP as one of several factors involved in the 3' end maturation of histone premessenger RNAs. Science 238: 1682-1687, 1987.
30. Mirabelli CK, Bennett CF, Anderson K and Crooke ST: In vitro and in vivo pharmacologic antisense oligonucleotides. Anti-Cancer Drug Design 6: 647-661, 1991
31. Perlaky L, Saijo Y, Busch RK, Bennett CF, Mirabelli CK, Crooke ST and Busch H: Growth inhibition of human tumor cell lines by antisense oligonucleotides designed to inhibit p120 expression. Anti-Cancer Drug Design 8: 3-14, 1993.
32. Chu E, Voeller DM, Casey JL, Drake JC, Chabner BA, Elwood PC, Zinn S and Allegra C: Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase. Proc Natl Acad Sci USA 88: 8977-8981, 1991.
33. Chu E, Voeller DM, Jones K, Takechi T, Maley GF, Maley F, Segal S and Allegra C: Identlfication of a thymidylate synthase ribonucleoprotein complex in human colon cancer cells. Mol Cell Biol 14: 207-213, 1994.
34. Ayusawa D, Shimizu K, Koyama H, kaneda S, Takeishi K and Seno T: Cell-cycle-directed regulation of thymidylate synthase messenger RNA in human diploid fibrobrasts stimulated to proliferate. J Mol Biol 190: 559-567, 1986.
35. Takayanagi A, Kaneda S, Ayusawa D and Seno T: Intron 1 and the 5'-franking region of human thymidylate synthase as a regulatory determinant of growth-dependent expression. Nucleic Acids Res 20: 4021-4025, 1992.
36. Deng T, Li Y and Johnson LF: Thymidylate synthase gene expression is stimulated by some (but not all) introns. Nucleic Acids Res 17: 645-658, 1989.
37. Husain I, Mohler JL, Seigler, HF and Besterman JM: Elevation of topoisomerase I messenger RNA, protein and catalytic activity in human tumors: Demonstration of tumor-type specificity and implications for cancer chemotherapy. Cancer Res 54: 539-546, 1994.
38. Chu E, Takimoto CH, Voeller D, Grem JL and Allegra CJ: Specific binding of human dihydrofolate reductase protein to dihydrofolate reductase messenger RNA in vitro. Biochemistry 32: 4756-4760, 1993.